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Abstract
Background: Dimension reduction is a critical issue in the analysis of microarray data, because
the high dimensionality of gene expression microarray data set hurts generalization performance
of classifiers. It consists of two types of methods, i.e. feature selection and feature extraction.
Principle component analysis (PCA) and partial least squares (PLS) are two frequently used feature
extraction methods, and in the previous works, the top several components of PCA or PLS are
selected for modeling according to the descending order of eigenvalues. While in this paper, we
prove that not all the top features are useful, but features should be selected from all the
components by feature selection methods.
Results: We demonstrate a framework for selecting feature subsets from all the newly extracted
components, leading to reduced classification error rates on the gene expression microarray data.
Here we have considered both an unsupervised method PCA and a supervised method PLS for
extracting new components, genetic algorithms for feature selection, and support vector machines
and  k  nearest neighbor for classification. Experimental results illustrate that our proposed
framework is effective to select feature subsets and to reduce classification error rates.
Conclusion: Not only the top features newly extracted by PCA or PLS are important, therefore,
feature selection should be performed to select subsets from new features to improve
generalization performance of classifiers.
Background
Tumor classification is performed on microarray data col-
lected by DNA microarray experiments from tissue and
cell samples [1-3]. The wealth of this kind of data in dif-
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ferent stages of cell cycles helps to explore gene interac-
tions and to discover gene functions. Moreover, obtaining
genome-wide expression data from tumor tissues gives
insight into the gene expression variation of various
tumor types, thus providing clues for tumor classification
of individual samples. The output of microarray experi-
ment is summarized as an n × p data matrix, where n is the
number of tissue or cell samples; p is the number of genes.
Here p is always much larger than n, which hurts general-
ization performance of most classification methods. To
overcome this problem, dimension reduction methods
are applied to reduce the dimensionality from p to q with
q <<> p.
Dimension reduction usually consists of two types of
methods, feature selection and feature extraction [4]. Fea-
ture selection chooses a subset from original features
according to classification performance, the optimal sub-
set should contain relevant but non redundant features.
Feature selection can help to improve generalization per-
formance and speed of classifiers. There have been a great
deal of work in machine learning and related areas to
address this issue [5-9]. But in most practical cases, rele-
vant features are not known beforehand. Finding out
which features to be used is a hard work. At the same time,
feature selection will lose the relevant information among
features, while feature extraction is good at handling inter-
actions among features.
Feature extraction projects the whole data into a low
dimensional space and constructs the new dimensions
(components) by analyzing the statistical relationship
hidden in the data set. Principle components analysis
(PCA) is one of the frequently used methods for feature
extraction of microarray data. It is unsupervised, since it
need not the label information of the data sets. Partial
Least Squares (PLS) is one of the widely used supervised
feature extraction methods for analysis of gene expression
microarray data [10,11], it represents the data in a low
dimensional space through linear transformation.
Although feature extraction methods produce independ-
ent features, but Usually, a large number of features are
extracted to represent the original data. As we known, the
extracted features also contain noise or irrelevant informa-
tion. Choosing an appropriate set of features is critical.
Some researcher considered that the initial several compo-
nents of PLS contain more information than the others,
but it is hard to decide how many tail components are
trivial for discrimination. Some authors proposed to fixed
the number of components from three to five [12]; some
proposed to determine the size of the space by classifica-
tion performance of cross-validation [13]. However each
one has its own weakness. Fixing at an arbitrary dimen-
sional size is not applicable to all data sets, and the cross-
validation method is often obstructed by its high compu-
tation. An efficient and effective model selection method
for PLS is demanded. Furthermore, we consider not all the
initial components are important for classification, sub-
sets should be selected for classification.
Here, we propose and demonstrate the importance of fea-
ture selection after feature extraction in the tumor classifi-
cation problems. We have performed experiments by
using PCA [14] and PLS [15] as feature extraction meth-
ods separately. In this paper, we will perform a systematic
study on both PCA and PLS methods, which will be com-
bined with the feature selection methods (Genetic Algo-
rithm) to get more robust and efficient dimensional
space, and then the constructed data from the original
data is used with Support Vector Machine (SVM) and k
Nearest Neighbor (kNN) for classification. By applying
the systematic study on the analysis of gene microarray
data, we try to study whether feature selection selects
proper components for PCA and PLS dimension reduc-
tion and whether only the top components are nontrivial
for classification.
Results and discussion
Results by using SVM
In order to demonstrate the importance of feature selec-
tion in dimension reduction, we have performed the fol-
lowing series experiments by using support vector
machine (SVM) as the classifier:
1. SVM is a baseline method, all the genes without any
selection and extraction are input into SVM for classifica-
tion.
2. PCASVM uses PCA as feature extraction methods, all
the newly extracted components are input into SVM.
3. PLSSVM uses PLS as feature extraction methods, all the
newly extracted components are input into SVM.
4. PPSVM uses PCA+PLS as feature extraction methods, all
the newly extracted components are input into SVM.
5. GAPCASVM uses PCA as feature extraction methods to
extract new components from original gene set and GA as
feature selection methods to select feature subset from the
newly extracted components, the selected subset is input
into SVM.
6. GAPLSSVM uses PLS as feature extraction methods to
extract new components from original gene set and GA as
feature selection methods to select feature subset from the
newly extracted components, the selected subset is input
into SVM.BMC Genomics 2008, 9(Suppl 2):S24 http://www.biomedcentral.com/1471-2164/9/S2/S24
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7. GAPPSVM uses PCA+PLS as feature extraction methods
to extract new components from original gene set and GA
as feature selection methods to select feature subset from
the newly extracted components, the selected subset is
input into SVM.
Since there are parameters for SVM, we try to reduce its
effect to our comparison and use four pairs of different
parameters for SVM, they are C = 10, σ = 0.01, C = 10, σ =
10, C = 1000, σ = 0.01, and C = 1000, σ = 10. It is noted
that different data sets including the extracted data sets
and selected data sets need different optimal parameters
for different methods, we do not choose the optimal
parameters, because 1) this is unreachable, finding the
optimal parameters is an NP hard problem; 2) we do not
exhibit the top performance of one special method on one
single data set, but we want to show the effect of our pro-
posed framework.
Prediction performance
The average error rates and the corresponding standard
deviation values are shown in Table 1, where the standard
deviation values are produced from our 50 times repeated
experiments. From Table 1, we can find that:
￿ Results of all the classification methods with feature
selection and extraction like PLSSVM, GAPLSSVM,
PCASVM, GAPCASVM, GAPPSVM are better than that of
SVM without any dimension reduction on average. Only
on the LUNG data set, when SVM uses parameters of C =
10, σ = 0.01, results of PPSVM are worse than those of
SVM.
￿ Results of classification methods with feature selection
like GAPLSSVM, GAPCASVM and GAPPSVM are better
than those of the corresponding feature extraction meth-
ods without feature selection like PLSSVM, PCASVM and
PPSVM on average. Only on few cases, i.e. when C = 10, σ
= 10 is for SVM, results of GAPCASVM are slightly worse
than those of PCASVM on the COLON data set.
Table 1: Statistical classification error rates (and their corresponding standard deviation) by using SVM with different parameters on 
four microarray data sets (%)
DATASET SVM PCASVM GAPCASVM PLSSVM GAPLSSVM PPSVM GAPPSVM
C = 10, σ = 0.01 for SVM
CNS 40.4(8.6) 36.4(4.4) 35.2(1.6) 36.6(2.8) 35.0(5.6) 36.2(5.3) 35.0(7.0)
COLON 34.6(5.4) 31.3(7.0) 29.6(7.5) 29.5(8.2) 28.8(9.2) 33.2(6.7) 30.5(7.2)
LEUKEMIA 27.0(7.1) 26.2(6.1) 23.2(6.4) 20.4(7.0) 16.2(5.9) 22.9(7.5) 21.7(7.2)
LUNG 4.2(7.2) 4.1(5.9) 3.9(6.2) 3.7(6.2) 3.3(5.8) 4.4(5.5) 4.0(7.3)
Average 26.8(7.1) 24.5(5.9) 22.9(5.4) 22.5(6.1) 20.8(6.7) 24.1(6.2) 22.8(7.2)
C = 10, σ = 10 for SVM
CNS 40.6(9.2) 35.7(4.2) 34.4(7.3) 39.6(7.5) 38.4(5.5) 40.0(5.3) 38.7(8.3)
COLON 34.6(5.4) 29.1(8.3) 29.6(7.3) 29.7(8.3) 29.1(9.3) 33.7(6.9) 32.2(7.2)
LEUKEMIA 27.4(6.9) 26.3(6.2) 22.1(6.3) 20.4(7.0) 16.3(6.0) 22.8(7.3) 20.9(7.2)
LUNG 3.7(6.9) 2.9(6.2) 1.7(6.2) 1.6(6.8) 1.6(6.1) 1.6(8.5) 1.5(4.4)
Average 26.5(7.1) 23.4(6.2) 21.9(6.8) 22.8(7.4) 21.3(6.7) 24.5(6.9) 23.3(6.8)
C = 1000, σ = 0.01 for SVM
CNS 37.6(7.6) 35.4(1.7) 34.4(1.0) 36.1(2.9) 35.0(5.4) 36.0(5.0) 35.6(3.1)
COLON 33.7(5.2) 31.0(7.8) 29.9(7.3) 28.9(8.7) 27.8(9.3) 33.4(7.2) 30.1(8.0)
LEUKEMIA 26.8(7.2) 25.8(6.2) 23.3(6.3) 20.5(6.9) 16.4(9.5) 24.0(7.4) 21.0(7.1)
LUNG 4.2(6.9) 4.1(6.5) 3.2(6.2) 3.4(7.2) 3.4(8.4) 4.0(6.3) 3.3(5.8)
Average 25.6(6.8) 24.0(5.5) 22.7(5.2) 22.2(6.4) 20.6(8.2) 24.6(6.5) 22.9(6.0)
C = 1000, σ = 10 for SVM
CNS 41.4(8.7) 35.4(8.6) 34.0(8.4) 40.9(7.6) 38.9(5.8) 42.5(9.1) 39.2(8.8)
COLON 33.9(6.0) 31.0(7.5) 29.7(7.0) 29.0(8.7) 28.5(9.3) 32.8(7.2) 29.7(8.0)
LEUKEMIA 27.9(7.2) 25.0(6.1) 23.1(6.6) 20.5(6.9) 16.4(5.9) 22.6(7.7) 21.1(7.3)
LUNG 3.9(5.8) 2.8(6.5) 1.3(6.8) 1.7(6.3) 1.4(6.9) 3.6(6.3) 1.3(6.4)
Average 26.7(6.9) 23.5(7.2) 22.0(7.2) 23.0(7.3) 21.2(7.0) 25.4(7.6) 22.8(7.6)BMC Genomics 2008, 9(Suppl 2):S24 http://www.biomedcentral.com/1471-2164/9/S2/S24
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￿ Results of GAPLSSVM are better than those of PCASVM
and GAPCASVM, even the corresponding results of
PPSVM and GAPPSVM on average. Only on the CNS data
set out of four data sets, GAPCASVM obtains the best
results than other methods do.
￿ Results of PPSVM and GAPPSVM which combine PCA
and PLS as feature extraction methods are not the best,
just equal with those of PCASVM and GAPCASVM.
Number of selected features
We also show the number of features selected by each
method with their corresponding standard deviation in
Table 2, where the standard deviation values are produced
from our 50 times repeated experiments. The values for
PCASVM means the ratios of the number of top principle
components to that of extracted components, those of
PLSSVM and PPSVM have the same meaning. The values
for GAPCASVM means the ratios of the number of
selected components used in SVM to that of extracted
components, and those of GAPLSSVM and GAPPSVM
have the same meaning. From Table 2, we can see that if
we use the top components, about 60–80% components
are selected into learning machines, while if we use feature
selection to select useful components, about 30% compo-
nents are selected on average. Only on the LUNG data set,
the selected components by different methods are
70%–80% of extracted components.
Distribution of selected features
Fig. 1 shows the comparison of distributions of compo-
nents selected by GA in two cases of GAPCASVM and
GAPLSSVM, and Fig. 2 shows that of GAPPSVM. Differ-
ence between Fig. 1 and Fig. 2 is that in Fig. 1, PCA and
PLS are used as feature extraction individually, while in
Fig. 2, PCA is combined with PLS as feature extraction
methods.
From Fig. 1 and Fig. 2, we can find that:
Table 2: Average percentage of features (and their corresponding standard deviation) used by SVM with different parameters on four 
microarray data sets (%)
DATASET PCASVM GAPCASVM PLSSVM GAPLSSVM PPSVM GAPPSVM
C = 10, σ = 0.01 for SVM
CNS 74.4(8.5) 27.3(8.3) 67.7(10.0) 29.4(8.4) 68.8(6.6) 30.8(8.6)
COLON 81.1(7.5) 28.5(8.9) 57.6(4.8) 30.8(7.4) 59.4(9.2) 31.1(7.4)
LEUKEMIA 78.0(9.8) 26.7(6.3) 46.8(10.1) 30.0(6.5) 52.0(9.3) 30.3(6.6)
LUNG 82.2(6.2) 74.7(6.2) 73.8(7.9) 72.0(3.6) 82.3(7.6) 73.3(5.7)
Average 78.9(8.0) 39.3(7.4) 61.4(8.2) 40.5(6.5) 65.6(8.2) 41.3(7.1)
C = 10, σ = 10 for SVM
CNS 73.4(9.8) 27.4(8.0) 62.7(9.0) 29.6(8.5) 65.7(9.3) 20.7(8.3)
COLON 82.1(6.5) 28.7(8.9) 57.6(4.8) 30.6(7.3) 59.3(8.3) 31.1(7.5)
LEUKEMIA 87.0(9.1) 26.7(6.1) 46.8(10.0) 30.0(6.3) 49.3(8.3) 30.4(6.7)
LUNG 77.4(7.0) 74.4(6.7) 76.3(6.9) 73.1(3.0) 83.1(8.1) 72.0(6.3)
Average 79.4(8.1) 39.3(7.4) 60.8(7.7) 40.8(6.3) 64.4(8.5) 38.5(7.2)
C = 1000, σ = 0.01 for SVM
CNS 78.1(8.0) 27.4(8.2) 64.3(9.0) 29.3(8.3) 70.1(9.1) 30.6(8.3)
COLON 80.9(7.4) 28.1(8.6) 57.6(5.2) 30.7(7.3) 62.2(8.2) 31.0(7.5)
LEUKEMIA 87.1(9.7) 27.0(6.7) 47.6(10.0) 30.4(7.3) 49.2(8.3) 30.4(6.8)
LUNG 79.0(6.6) 76.8(6.3) 77.2(7.1) 67.4(4.3) 84.4(7.9) 81.4(6.6)
Average 81.3(7.9) 39.8(7.4) 61.6(7.8) 39.4(6.8) 66.4(8.4) 43.3(7.3)
C = 1000, σ = 10 for SVM
CNS 76.2(8.9) 27.4(8.4) 67.1(8.9) 29.2(7.7) 69.4(9.1) 30.6(8.3)
COLON 82.5(7.2) 28.0(8.7) 59.5(4.6) 30.7(7.3) 63.3(8.7) 32.2(7.4)
LEUKEMIA 88.2(9.7) 27.3(6.7) 47.6(8.1) 30.3(7.3) 49.2(7.9) 30.4(6.8)
LUNG 81.1(6.8) 78.2(6.1) 81.3(5.1) 77.6(8.2) 81.1(8.0) 76.4(5.9)
Average 82.0(8.1) 40.2(7.0) 63.8(6.7) 41.9(7.6) 65.7(8.4) 42.4(7.1)BMC Genomics 2008, 9(Suppl 2):S24 http://www.biomedcentral.com/1471-2164/9/S2/S24
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￿ When only PLS is used for feature extraction, the top
components are a little more than that of others in the
selected components, but the others are also important.
￿ When only PCA is used, the top components is less than
others in the selected features, and the tail components
are more important than others.
￿ When both PCA and PLS are used as feature extraction
methods, they are nearly equal in the selected compo-
nents, and the top components of PLS is a little more than
others.
Results by using kNN
In order to show the importance of feature selection, we
have also performed the following series experiments on
the kNN learning machine to reduce the bias caused by
learning machines.
1. KNN is a baseline method, all the genes without any
selection and extraction are input into kNN for classifica-
tion.
2. PCAKNN uses PCA as feature extraction methods, all
the newly extracted components are input into kNN.
3. PLSKNN uses PLS as feature extraction methods, all the
newly extracted components are input into kNN.
4. PPKNN uses PCA+PLS as feature extraction methods,
all the newly extracted components are input into kNN.
5. GAPCAKNN uses PCA as feature extraction methods to
extract new components from original gene set and GA as
feature selection methods to select feature subset from the
newly extracted components, the selected subset is input
into kNN.
Comparison of distributions of eigenvectors used by GAPCASVM and GAPLSSVM with C = 10, σ = 0.01 for SVM Figure 1
Comparison of distributions of eigenvectors used by GAPCASVM and GAPLSSVM with C = 10, σ = 0.01 for 
SVM. X-axis corresponds to the eigenvectors in descending order by their eigenvalues and has been divided into bins of size 5. 
Y-axis corresponds to the average value of times that eigenvectors within some bin are selected by GA.
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6. GAPLSKNN uses PLS as feature extraction methods to
extract new components from original gene set and GA as
feature selection methods to select feature subset from the
newly extracted components, the selected subset is input
into kNN.
7. GAPPKNN uses PCA+PLS as feature extraction methods
to extract new components from original gene set and GA
as feature selection methods to select feature subset from
the newly extracted components, the selected subset is
input into kNN.
Since there are parameters for kNN, we try to reduce its
effect to our comparison and use three parameters for
kNN, they are k = 1, k = 4 and k = 7.
It is noted that different data sets need different optimal
parameters for different methods, we do not choose the
optimal parameters, because we do not exhibit the top
performance of one special method on one single data set,
but we want to show the effect of our proposed frame-
work.
Prediction performance
The average error rates and the corresponding standard
deviation values are shown in Table 3, from which we can
find the similar observations:
￿ Results of all the classification methods with feature
selection and extraction like PLSKNN, GAPLSKNN,
PCAKNN, GAPCAKNN, GAPPKNN are better than that of
KNN without any other dimension reduction on average
and on each cases.
￿ Results of classification methods with feature selection
like GAPLSKNN, GAPCAKNN and GAPPKNN are better
than those of the corresponding feature extraction meth-
ods without feature selection like PLSKNN, PCAKNN and
PPKNN on average and each cases.
Comparison of distributions of eigenvectors used by GAPPSVM with C = 10, σ = 0.01 for SVM Figure 2
Comparison of distributions of eigenvectors used by GAPPSVM with C = 10, σ = 0.01 for SVM. X-axis corre-
sponds to the eigenvectors in descending order by their eigenvalues and has been divided into bins of size 5. Y-axis corre-
sponds to the average value of times that eigenvectors within some bin are selected by GA.
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Table 3: Statistical classification error rates (and their corresponding standard deviation) by using kNN with different different 
parameters on four microarray data sets (%)
DATASET KNN PCAKNN GAPCAKNN PLSKNN GAPLSKNN PPKNN GAPPKNN
k = 1 for kNN
CNS 47.5(3.5) 43.8(8.7) 40.8(10.2) 44.9(9.3) 36.4(10.7) 44.9(10.3) 34.3(8.3)
COLON 32.5(1.4) 28.4(8.4) 27.1(10.3) 24.8(14.3) 21.9(7.5) 30.2(12.2) 18.2(7.2)
LEUKEMIA 16.1(2.2) 14.7(10.8) 11.4(8.7) 15.7(10.4) 12.3(8.6) 15.9(11.9) 8.4(6.4)
LUNG 17.6(2.3) 11.8(7.1) 11.0(4.6) 11.8(5.3) 6.1(4.7) 13.2(5.6) 7.8(4.1)
Average 28.4(2.3) 24.6(8.7) 22.57(8.4) 24.3(9.8) 19.2(7.8) 25.3(10.0) 17.1(6.5)
k = 4 for kNN
CNS 48.6(1.2) 46.5(11.2) 41.5(11.0) 44.9(9.9) 38.4(10.8) 47.8(9.9) 38.5(8.7)
COLON 44.6(2.8) 42.9(12.9) 36.2(9.2) 35.3(14.3) 28.8(8.8) 34.9(13.7) 24.5(8.4)
LEUKEMIA 32.5(1.9) 31.5(14.1) 28.1(11.9) 15.5(9.6) 14.8(14.9) 18.6(11.5) 10.0(7.8)
LUNG 16.2(0.8) 15.8(4.6) 13.5(4.8) 12.6(6.3) 10.1(4.8) 13.4(6.5) 9.4(3.5)
Average 35.4(1.7) 34.1(10.7) 28.8(9.2) 27.0(10.0) 23.0(8.0) 28.67(10.4) 20.6(7.1)
k = 7 for kNN
CNS 46.5(1.4) 39.1(6.6) 38.6(6.8) 41.4(10.3) 39.4(9.4) 39.0(9.0) 31.9(7.6)
COLON 30.9(1.0) 28.4(8.4) 26.0(8.3) 28.3(11.6) 24.3(8.3) 25.8(11.0) 19.5(7.2)
LEUKEMIA 24.3(1.0) 22.7(10.2) 17.7(9.1) 13.5(9.0) 11.5(8.8) 12.4(8.0) 7.0(6.2)
LUNG 16.3(0.6) 13.2(3.6) 10.1(3.5) 11.5(4.1) 6.5(4.7) 12.1(5.4) 7.5(3.61)
Average 29.5(1.0) 25.8(7.2) 23.1(6.9) 23.6(8.7) 20.4(7.8) 22.42(8.3) 16.4(6.2)
Table 4: Average percentage of features (and their corresponding standard deviation) used by kNN with different parameters on four 
microarray data sets (%)
DATASET PCAKNN GAPCAKNN PLSKNN GAPLSKNN PPKNN GAPPKNN
k = 1 for kNN
CNS 68.5(6.5) 32.3(8.0) 69.2(8.0) 32.2(6.4) 62.5(7.3) 32.3(9.1)
COLON 78.2(4.4) 29.7(7.8) 58.3(5.2) 32.8(6.4) 61.4(9.0) 34.2(7.2)
LEUKEMIA 68.0(8.8) 28.6(6.2) 47.8(7.1) 31.2(7.6) 54.3(8.3) 33.3(6.8)
LUNG 73.4(6.2) 72.2(7.6) 78.4(7.2) 68.9(5.9) 79.8(8.1) 71.9(6.9)
Average 72.0(6.5) 40.7(7.4) 63.4(6.9) 41.2(6.6) 64.5(8.2) 42.9(7.5)
k = 4 for kNN
CNS 71.2(6.8) 26.6(7.9) 68.2(7.8) 31.6(9.5) 62.4(9.8) 23.1(8.2)
COLON 80.3(7.5) 32.2(6.8) 59.7(5.2) 27.3(8.3) 62.3(8.8) 32.5(7.5)
LEUKEMIA 81.4(6.9) 26.7(5.7) 46.8(8.8) 35.5(7.1) 50.7(7.3) 33.2(6.0)
LUNG 78.2(8.7) 71.2(6.3) 74.7(6.0) 69.3(4.1) 80.2(8.9) 70.0(6.2)
Average 77.7(7.5) 39.1(6.7) 62.3(6.9) 40.9(7.2) 63.9(8.7) 39.7(7.0)
k = 7 for kNN
CNS 72.8(7.1) 29.4(8.2) 61.7(8.8) 32.3(6.1) 68.1(10.3) 32.0(8.8)
COLON 81.2(8.3) 25.7(7.7) 52.4(6.3) 36.7(5.7) 65.4(8.9) 33.4(7.3)
LEUKEMIA 79.1(6.9) 28.9(6.5) 48.9(9.1) 32.1(6.8) 51.3(9.1) 32.7(6.1)
LUNG 80.0(5.2) 72.5(8.7) 78.3(7.4) 62.9(7.6) 82.7(9.2) 80.9(5.8)
Average 78.2(6.9) 39.1(7.8) 60.3(7.9) 41.0(6.6) 66.8(9.4) 44.7(7.0)BMC Genomics 2008, 9(Suppl 2):S24 http://www.biomedcentral.com/1471-2164/9/S2/S24
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￿ Different from results by using SVM, results of GAPP-
KNN are better than those of PCAKNN and GAPCAKNN,
even the corresponding results of PLSKNN and
GAPLSKNN on average. Only on the Lung data set out of
four data sets, GAPLSKNN obtains the best results than
other methods do.
￿ Compared with results by using SVM, on the CNS,
Colon and Leukemia data sets, results by using kNN are
better, while on the Lung data set, results by kNN are
worse. But we can not compare learning machines by
these results because we did not optimize the parameters.
Number of selected features
We also show the number of features selected by each
method in Table 4, where the values for PCAKNN means
the ratios of the number of top principle components to
that of extracted components, those of PLSKNN and
PPKNN have the same meaning. The values for GAP-
CAKNN means the ratios of the number of selected com-
ponents used in kNN to that of extracted components,
and those of GAPLSKNN and GAPPKNN have the same
meaning.
From Table 4, we can see that if we use the top compo-
nents as in PCAKNN, PLSKNN and PPKNN, about
60–80% components are selected into learning machines,
while if we use feature selection to select useful compo-
nents as in GAPCAKNN, GAPLSKNN and GAPPKNN,
about 30% components are selected on average. Only on
the LUNG data set, the selected by different methods are
70–80% of extracted components.
Distribution of selected features
Fig. 3 shows the comparison of distributions of compo-
nents selected by GA in two cases of GAPCAKNN and
GAPLSKNN, and Fig. 4 shows that of GAPPKNN. Differ-
ence between Fig. 3 and Fig. 4 is that in Fig. 3, PCA and
PLS are used as feature extraction individually, while in
Comparison of distributions of eigenvectors used by GAPCAKNN and GAPLSKNN with k = 1 for kNN Figure 3
Comparison of distributions of eigenvectors used by GAPCAKNN and GAPLSKNN with k = 1 for kNN. X-axis 
corresponds to the eigenvectors in descending order by their eigenvalues and has been divided into bins of size 5. Y-axis cor-
responds to the average value of times that eigenvectors within some bin are selected by GA.
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Fig. 4, PCA is combined with PLS as feature extraction
methods.
From Fig. 3 and Fig. 4, we can find the similar observa-
tions as below:
￿ When only PLS is used for feature extraction, the top
components are more than that of others in the selected
components, but the others are also selected, the top, the
more.
￿ When only PCA is used, the top components is less than
others in the selected features, and the tail components
are more important than others.
￿ When both PCA and PLS are used as feature extraction
methods, they are nearly equal in the selected compo-
nents, and the top components of PLS are a little more
than others.
Discussion
The results are interesting, beyond our imagination, but
they are reasonable.
From the experimental results, we know not the top com-
ponents are important. The reason can be found in the
subsection of feature extraction. For PCA, components are
extracted by maximizing the variance of a linear combina-
tion of the original genes,
, but not maximiz-
ing the discriminative power for classifiers like support
vector machine (SVM) and k  nearest neighbor (kNN).
Therefore, the top component of PCA is not the top one
with high discriminative power of classifiers. For PLS,
components are extracted by maximizing the covariance
between the response variable y and the original genes X,
. Therefore, the top com- ww y ww q t X = = argmax ( ( , )) 1 Cov
Comparison of distributions of eigenvectors used by GAPPKNN with k = 1 for kNN Figure 4
Comparison of distributions of eigenvectors used by GAPPKNN with k = 1 for kNN. X-axis corresponds to the 
eigenvectors in descending order by their eigenvalues and has been divided into bins of size 5. Y-axis corresponds to the aver-
age value of times that eigenvectors within some bin are selected by GA.
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ponent of PLS is more important than the others for clas-
sifiers. Furthermore, the top components of PCA are not
the top feature subset with high discriminative power for
classifiers, while the top ones of PLS are the top feature
subset with high discriminative power, but the tail ones
have also discriminative power, they are selected too. So,
we should not only choose the top components, but
employ feature selection methods to select a feature sub-
set from the extracted components for classifiers.
Feature selection is performed by genetic algorithm (GA),
which shows great power to select feature subsets for clas-
sifiers, this can be seen from the experimental results.
Here genetic algorithm based feature selection is a so
called wrapper model, which uses the classifier to measure
the discriminative power of feature subsets from the
extracted components. This method has been proved the
best one feature selection method [16]. While this wrap-
per method is time consuming, nowadays, the scale of
data sets is increasing rapidly, so efficient feature selection
methods need be developed.
Partial least squares is superior to principle component
analysis as feature extraction methods. The reason is sim-
ple, PLS extracts components by maximizing the covari-
ance between the response variable y  and the original
genes X, which considers using the labels y and can be
viewed as a supervised method. While PCA extracts com-
ponents by maximizing the variance of a linear combina-
tion of the original genes, which does not consider using
the label y and can be viewed as an unsupervised method.
Here, we try to improve the classification accuracy of SVM,
this is a supervised task, so PLS a supervised method is
superior to PCA, an unsupervised method.
Features selected by different classifiers has minor differ-
ence, and results of prediction accuracy are also different.
Feature selection has done more effect on kNN than that
on SVM. Because kNN is more sensitive on high dimen-
sional data sets than SVM. But, they all benefit from fea-
ture selection.
Conclusion
We have investigated a systematic feature reduction
framework by combing feature extraction with feature
selection. To evaluate the proposed framework, we used
four typical data sets. In each case, we used principle com-
ponent analysis (PCA) and partial least squares (PLS) for
feature extraction, GA as feature selection, support vector
machine (SVM) and k nearest neighbor (kNN) for classifi-
cation. Our experimental results illustrate that the pro-
posed method improves the performance on the gene
expression microarray data in accuracy. Further study of
our experiments indicates that not all the top components
of PCA and PLS are useful for classification, the tail com-
ponent also contain discriminative information. There-
fore, it is necessary to combine feature selection with
feature extraction and replace the traditional feature
extraction step as a new preprocessing step for analyzing
high dimensional problems.
Methods
A novel framework of dimension reduction
Principle Components Analysis (PCA) and Partial Least
Squares (PLS) are two favorite methods in gene analysis,
but how to determine the number of extracted compo-
nents for classifiers is a critical problem. In the previous
works, the number is fixed as 3 or 5 top ones, or obtained
by cross validation. These works assume that only the top
several components are important. In fact the compo-
nents are ranked from a statistical view; it may not the
same rank according to their discriminative ability. There-
fore, we propose to apply feature selection techniques to
select components for classifiers. Fig. 5 illustrates the
main steps of the framework employed here. The main
difference from the traditional approach is the inclusion
of a step that performs feature selection among the fea-
tures extracted by feature extraction methods. From Fig. 5,
we can see that dimension reduction consists of two parts,
feature extraction and feature selection, here feature
extraction is performed by PCA and PLS, feature selection
is performed by GA and classifier is performed by support
vector machine (SVM) or k nearest neighbor (kNN). In
Fig. 5, classifier is also applied to feature selection, that is
also so call the wrapper evaluation strategy, classification
performance of classifiers is used to evaluate the selected
feature subset. These are explained in detail as follows.
Feature extraction
Principle component analysis
PCA is a well-known method of dimension reduction
[17]. The basic idea of PCA is to reduce the dimensionality
of a data set, while retaining as much as possible the vari-
A framework of dimension reduction for the analysis of gene  microarray data Figure 5
A framework of dimension reduction for the analysis of gene 
microarray data.BMC Genomics 2008, 9(Suppl 2):S24 http://www.biomedcentral.com/1471-2164/9/S2/S24
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ation present in the original predictor variables. This is
achieved by transforming the p original variables X = [x1,
x2,..., xp] to a new set of q predictor variables, T = [t1, t2,...,
tq], which are linear combinations of the original varia-
bles. In mathematical terms, PCA sequentially maximizes
the variance of a linear combination of the original pre-
dictor variables,
subject to the constraint  , for all 1 ≤ i <j. The
orthogonal constraint ensures that the linear combina-
tions are uncorrelated, i.e. Cov(Xui, Xuj) = 0, i ≠ j. These
linear combinations
ti = Xui (2)
are known as the principal components (PCs). Geometri-
cally, these linear combinations represent the selection of
a new coordinate system obtained by rotating the original
system. The new axes represent the directions with maxi-
mum variability and are ordered in terms of the amount
of variation of the original data they account for. The first
PC accounts for as much of the variability as possible, and
each succeeding component accounts for as much of the
remaining variability as possible. Computation of the
principal components reduces to the solution of an eigen-
value-eigenvector problem. The projection vectors (or
called the weighting vectors) u can be obtained by eigen-
value decomposition on the covariance matrix SX,
SXui = λiui (3)
where λi is the i-th eigenvalue in the descending order for
i = 1,..., q, and ui is the corresponding eigenvector. The
eigenvalue λi measures the variance of the i-th PC and the
eigenvector ui provides the weights (loadings) for the lin-
ear transformation (projection).
The maximum number of components q is determined by
the number of nonzero eigenvalues, which is the rank of
SX, and q ≤ min(n, p). But in practical, the maximum value
of q is not necessary. Some tail components, which have
tiny eigenvalues and represent few variances of original
data, are often needed to be reduced. The threshold of q
often determined by cross-validation or the proportion of
explained variances [17]. The computational cost of PCA,
determined by the number of original predictor variables
p and the number of samples n, is in the order of min(np2
+ p3, pn2 + n3). In other words, the cost is O(pn2+ n3) when
p > n.
Partial least squares based dimension reduction
Partial Least Squares (PLS) was firstly developed as an
algorithm performing matrix decompositions, and then
was introduced as a multivariate regression tool in the
context of chemometrics [18,19]. In recent years, PLS has
also been found to be an effective dimension reduction
technique for tumor discrimination [11,12,20], which
denoted as Partial Least Squares based Dimension Reduc-
tion (PLSDR).
The underlying assumption of PLS is that the observed
data is generated by a system or process which is driven by
a small number of latent (not directly observed or meas-
ured) features. Therefore, PLS aims at finding uncorre-
lated linear transformations (latent components) of the
original predictor features which have high covariance
with the response features. Based on these latent compo-
nents, PLS predicts response features y, the task of regres-
sion, and reconstruct original matrix X, the task of data
modeling, at the same time.
The objective of constructing components in PLS is to
maximize the covariance between the response variable y
and the original predictor variables X,
subject to the constraint  , for all 1 ≤ i <j. The
central task of PLS is to obtain the vectors of optimal
weights wi (i = 1,..., q) to form a small number of compo-
nents, while PCA is an "unsupervised" method that uti-
lizes the X data only.
To derive the components, [t1, t2,..., tq], PLS decomposes
X and y to produce a bilinear representation of the data
[21]:
and
where w's are vectors of weights for constructing the PLS
components t = Xw, v's are scalars, and e and f are the
residuals. The idea of PLS is to estimate w and v by regres-
sion. Specifically, PLS fits a sequence of bilinear models
by least squares, thus given the name partial least squares
[18].
At each step i (i = 1,..., q), the vector wi is estimated in such
a way that the PLS component, ti, has maximal sample
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covariance with the response variable y subject to being
uncorrelated with all previously constructed components.
The first PLS component t1 is obtained based on the cov-
ariance between X and y. Each subsequent component ti (i
= 2,..., q), is computed using the residuals of X and y from
the previous step, which account for the variations left by
the previous components. As a result, the PLS compo-
nents are uncorrelated and ordered.
The number of components q is the only parameter of PLS
which can be decided by user [11,12], by cross-validation
[13] or by the regression goodness-of-fit [22]. With the
increase of q, the explained variances of X  and  y  are
expanded, and all the information of original data are pre-
served when q reaches the rank of X, which is the maximal
value of q.
Like PCA, PLS reduces the complexity of microarray data
analysis by constructing a small number of gene compo-
nents, which can be used to replace the large number of
original gene expression measures. Moreover, obtained by
maximizing the covariance between the components and
the response variable, the PLS components are generally
more predictive of the response variable than the princi-
pal components.
PLS is computationally efficient with cost only at O(npq),
i.e. the number of calculations required by PLS is a linear
function of n or p. Thus it is much faster than the method
of PCA for q is always less than n.
Feature selection
Finding out the optimal feature subset according to classi-
fication performance is referred to as feature selection.
Given a set of features, the problem is selecting a subset
that leads to the least classification error. A number of fea-
ture selection methods have been studied in the bioinfor-
matics and machine learning fields [6-8]. There are two
main components in every feature subset selection sys-
tem: the search strategy used to pick the feature subsets
and the evaluation method used to test their goodness
based on some criteria. Genetic algorithm as a search strat-
egy is proved to be the best one among different complete
and heuristic methods [16]. There are two categories of
evaluation strategies: 1) filter and 2) wrapper. The distinc-
tion is made depending on whether feature subset evalu-
ation is performed using the learning algorithm employed
in the classifier design (i.e., wrapper) or not (i.e., filter).
Filter approaches are computationally more efficient than
wrapper approaches since they evaluate the goodness of
selected features using criteria that can be tested quickly.
This, however, could lead to non-optimal features, espe-
cially, when the features dependent on the classifier. As
result, classifier performance might be poor. Wrapper
methods on the other hand perform evaluation by train-
ing the classification error using a validation set. Although
this is a slower procedure, the features selected are usually
more optimal for the classifier employed. Here we want to
improve classification performance, and use the wrapper
strategy. Classification performance of SVM or kNN is
used as the criteria in this paper.
Genetic algorithm
Genetic Algorithm (GA) is a class of optimization proce-
dures inspired by the biological mechanisms of reproduc-
tion. [23]. GA operate iteratively on a population of
structures, each one of which represents a candidate solu-
tion to the problem at hand, properly encoded as a string
of symbols (e.g., binary). Three basic genetic operators
guide this search: selection, crossover, and mutation. The
genetic search processes it iterative: evaluating, selecting,
and recombining strings in the population during each
iteration until reaching some termination condition.
The basic idea is that selection probabilistically filters out
solutions that perform poorly, choosing high perform-
ance solutions to concentrate on or exploit. Crossover and
mutation, through string operations, generate new solu-
tions for exploration. Given an initial population of ele-
ments, GA uses the feedback from the evaluation process
to select fitter solutions, generating new solutions through
recombination of parts of selected solutions, eventually
converging to a population of high performance solu-
tions.
In our proposed algorithm GA-FS (Genetic Algorithm
based Feature Selection), we use a binary chromosome
with the same length as the feature vector, which equals 1
if the corresponding feature is selected as the input, and 0
if the feature is discarded. The goal of using GA here is to
use fewer features to achieve the same or better perform-
ance. Therefore, the fitness evaluation contains two terms:
1) Classification error; 2) The number of selected features.
We use the fitness function shown below:
fitness = error + γ*number_of_selected_features,         (7)
where error corresponds to the classification error on the
validation data set Dv, γ is a trade-off between classifica-
tion error and the number of selected features. Here
between classification error and feature subset size, reduc-
ing classification error is our major concern, so γ is set to
1 = (2 * 104).
The GA-FS approach is summarized in Fig. 6, where the
data set is divided into 3 parts, training set Dr, validation
set Dv and test set Ds as in the subsection of experimental
setting.BMC Genomics 2008, 9(Suppl 2):S24 http://www.biomedcentral.com/1471-2164/9/S2/S24
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Classifier – support vector machines
Support vector machines (SVM) proposed by Vapnik and
his co-workers in 1990s, have been developed quickly
during the last decade [24], and successfully applied to
biological data mining [6], drug discovery [25,26], etc.
Denoting the training sample as {(X, y)} ⊆ {p × {-1,
1}}n, SVM discriminant hyperplane can be written as
y = sgn(w·X + b)
where n is the size of training sample, w is a weight vector,
b is a bias. According to the generalization bound in sta-
tistical learning theory [27], we need to minimize the fol-
lowing objective function for a 2-norm soft margin
version of SVM
in which, slack variable ξi is introduced when the problem
is infeasible. The constant C > 0 is a penalty parameter, a
larger C corresponds to assigning a larger penalty to errors.
By building a Lagrangian and using the Karush-Kuhn-
Tucker (KKT) complementarity conditions [28,29], we
can obtain the value of optimization problem (8).
Because of the KKT conditions, only those Lagrangian
multipliers, αis, which make the constraint active are non
zeros, we denote these points corresponding to the non
zero αis as support vectors (sv). Therefore we can describe
the classification hyperplane in terms of α and b:
where K(x, z) is a kernel function [30], it is introduced to
SVM to treat nonlinear cases, and Gaussian kernel func-
tion
K(x, z) = exp(-||x - z||2/σ2)
is considered as a prior choice [31].
Classifier – k nearest neighbor
k  nearest neighbor is a non-parametric classifier [32],
where the result of new instance is classified based on
majority of k nearest neighbor category, any ties can be
broken at random. It does not use any model to fit and
only based on the training data set.
Experimental data sets
Eight microarray data sets are used in our study which are
listed in Table 5. They are briefly described as below.
CNS [33] developed a classification system based on DNA
microarray gene expression data derived from patient
samples of Embryonal tumors of the central nervous sys-
tem (CNS). The data set used in our study contains 60
patient samples with 7,129 genes, 21 are survivors and 39
are failures.
Colon [2] used Affymetrix oligonucleotide arrays to mon-
itor expressions of over 6,500 human genes with samples
of 40 tumor and 22 normal colon tissues. Expression of
minimize
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Table 5: Microarray data sets used for comparison
Data Sets Samples Class Ratio Features
CNS 60 21/39 7,129
Colon 62 22/40 2,000
Leukemia 72 25/47 7,129
Lung 181 31/150 12,533
Genetic algorithm based feature selection Figure 6
Genetic algorithm based feature selection.BMC Genomics 2008, 9(Suppl 2):S24 http://www.biomedcentral.com/1471-2164/9/S2/S24
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the 2,000 genes with the highest minimal intensity across
the 62 tissues were used in the analysis.
Leukemia [1] consists of 72 bone marrow samples with
47 ALL and 25 AML. The gene expression intensities are
obtained from Affymetrix high-density oligonucleotide
microarrays containing probes for 7,129 genes.
Lung [34] proposed a data set for the purpose of classify-
ing lung Cancer between malignant pleural mesothe-
lioma (MPM) and adenocarcinoma (ADCA) of the lung.
The data set includes 181 tissue samples (31 MPM and
150 ADCA). Each sample is described by 12,533 genes.
Experimental settings
To evaluate the performance of the proposed approach,
we use the hold out validation procedure. Each data set is
used as a whole set, originally split data sets are merged,
and then we randomly divide the whole set into the train-
ing set and test set Ds (2/3 for training and the rest for
test). Furthermore, if a validation data set is needed, we
splits the training data set, keeping 2/3 samples for train-
ing Dr and the rest for validation Dv. Classification error of
SVM is obtained on the test data sets Ds. We repeat the
process 50 times.
The parameters of GA is set by default as in the software of
MATLAB, and we set different parameters for SVM and
kNN to test how parameters affect the results.
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